{"id":18394,"date":"2021-04-15T15:31:45","date_gmt":"2021-04-15T14:31:45","guid":{"rendered":"https:\/\/opa.org.uk\/?p=18394"},"modified":"2021-04-15T15:31:45","modified_gmt":"2021-04-15T14:31:45","slug":"cytosponge","status":"publish","type":"post","link":"https:\/\/opa-old.voidappsdev.uk\/?p=18394","title":{"rendered":"Cytosponge\u2122"},"content":{"rendered":"<p>Simple Clinic Test Offers Alternative to Endoscopy when Screening for Barrett\u2019s Oesophagus.<img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-18395 alignright\" src=\"https:\/\/opa.org.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk-300x182.jpg\" alt=\"\" width=\"300\" height=\"182\" srcset=\"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk-300x182.jpg 300w, https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk-150x91.jpg 150w, https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk-600x364.jpg 600w, https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg 696w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Cytosponge\u2122 is a new test that can identify Barrett\u2019s Oesophagus in at risk patients. It has been developed in the UK and is accurate, less invasive and relatively inexpensive compared to endoscopy.<\/p>\n<h3>Background<\/h3>\n<p>The incidence of oesophageal adenocarcinoma has increased six-fold since the 1970s and survival remains poor despite advances in surgery and chemotherapy. The overall 5-year survival is just 13%.<\/p>\n<p>Oesophageal adenocarcinoma is caused by gastro-oesophageal reflux disease (GORD). Reflux is very common; about 20% of adults in the UK suffer from heartburn symptoms caused by GORD. Of these it is estimated that 3-6% will have developed Barrett\u2019s Oesophagus. Barrett\u2019s is caused by reflux and is the precursor of most oesophageal cancers in the UK. However, only about 20% of patients with Barrett\u2019s oesophagus are diagnosed and therefore most people who develop oesophageal adenocarcinoma were unaware they had Barrett\u2019s.<\/p>\n<p>This article and image is from Reflux UK, <a href=\"https:\/\/refluxuk.com\/symptoms-and-diagnosis\/diagnostic-tests\/cytosponge\/\">click here to read more<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Simple Clinic Test Offers Alternative to Endoscopy when Screening for Barrett\u2019s Oesophagus. Cytosponge\u2122 is a new test that can identify Barrett\u2019s Oesophagus in at risk patients. It has been developed in the UK and is accurate, less invasive and relatively inexpensive compared to endoscopy. Background The incidence of oesophageal adenocarcinoma has increased six-fold since the 1970s and survival remains poor despite advances in surgery and chemotherapy. The overall 5-year survival is just 13%. Oesophageal adenocarcinoma is caused by gastro-oesophageal reflux disease (GORD). Reflux is very common; about 20% of adults in the UK suffer from heartburn symptoms caused by GORD. Of these it is estimated that 3-6% will have developed Barrett\u2019s Oesophagus. Barrett\u2019s is caused by reflux and is the precursor of most oesophageal cancers in the UK. However, only about 20% of patients with Barrett\u2019s oesophagus are diagnosed and therefore most people who develop oesophageal adenocarcinoma were unaware they had Barrett\u2019s. This article and image is from Reflux UK, click here to read more.<\/p>\n","protected":false},"author":4,"featured_media":18395,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-18394","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorised"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Cytosponge\u2122 - The OPA<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytosponge\u2122 - The OPA\" \/>\n<meta property=\"og:description\" content=\"Simple Clinic Test Offers Alternative to Endoscopy when Screening for Barrett\u2019s Oesophagus. Cytosponge\u2122 is a new test that can identify Barrett\u2019s Oesophagus in at risk patients. It has been developed in the UK and is accurate, less invasive and relatively inexpensive compared to endoscopy. Background The incidence of oesophageal adenocarcinoma has increased six-fold since the 1970s and survival remains poor despite advances in surgery and chemotherapy. The overall 5-year survival is just 13%. Oesophageal adenocarcinoma is caused by gastro-oesophageal reflux disease (GORD). Reflux is very common; about 20% of adults in the UK suffer from heartburn symptoms caused by GORD. Of these it is estimated that 3-6% will have developed Barrett\u2019s Oesophagus. Barrett\u2019s is caused by reflux and is the precursor of most oesophageal cancers in the UK. However, only about 20% of patients with Barrett\u2019s oesophagus are diagnosed and therefore most people who develop oesophageal adenocarcinoma were unaware they had Barrett\u2019s. This article and image is from Reflux UK, click here to read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/opa-old.voidappsdev.uk\/?p=18394\" \/>\n<meta property=\"og:site_name\" content=\"The OPA\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-15T14:31:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"696\" \/>\n\t<meta property=\"og:image:height\" content=\"422\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"OPA\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"OPA\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#article\",\"isPartOf\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394\"},\"author\":{\"name\":\"OPA\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/person\/60271f69edd5545b63ee48b7c7dfcb9f\"},\"headline\":\"Cytosponge\u2122\",\"datePublished\":\"2021-04-15T14:31:45+00:00\",\"dateModified\":\"2021-04-15T14:31:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394\"},\"wordCount\":169,\"publisher\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#organization\"},\"image\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage\"},\"thumbnailUrl\":\"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg\",\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394\",\"url\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394\",\"name\":\"Cytosponge\u2122 - The OPA\",\"isPartOf\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage\"},\"image\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage\"},\"thumbnailUrl\":\"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg\",\"datePublished\":\"2021-04-15T14:31:45+00:00\",\"dateModified\":\"2021-04-15T14:31:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/opa-old.voidappsdev.uk\/?p=18394\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage\",\"url\":\"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg\",\"contentUrl\":\"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg\",\"width\":696,\"height\":422},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/?p=18394#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/opa-old.voidappsdev.uk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytosponge\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#website\",\"url\":\"https:\/\/opa-old.voidappsdev.uk\/\",\"name\":\"The OPA\",\"description\":\"Caring for the cancer patient &amp; their family\",\"publisher\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/opa-old.voidappsdev.uk\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#organization\",\"name\":\"The Oesophageal Patients Association\",\"url\":\"https:\/\/opa-old.voidappsdev.uk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/opa.org.uk\/wp-content\/uploads\/2020\/12\/opa-logo-2020-site-icon.png\",\"contentUrl\":\"https:\/\/opa.org.uk\/wp-content\/uploads\/2020\/12\/opa-logo-2020-site-icon.png\",\"width\":512,\"height\":512,\"caption\":\"The Oesophageal Patients Association\"},\"image\":{\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/person\/60271f69edd5545b63ee48b7c7dfcb9f\",\"name\":\"OPA\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/73286462370642845c7dd15b380360bce9236d959ae2fc542c68da2e9ceb468f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/73286462370642845c7dd15b380360bce9236d959ae2fc542c68da2e9ceb468f?s=96&d=mm&r=g\",\"caption\":\"OPA\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytosponge\u2122 - The OPA","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_GB","og_type":"article","og_title":"Cytosponge\u2122 - The OPA","og_description":"Simple Clinic Test Offers Alternative to Endoscopy when Screening for Barrett\u2019s Oesophagus. Cytosponge\u2122 is a new test that can identify Barrett\u2019s Oesophagus in at risk patients. It has been developed in the UK and is accurate, less invasive and relatively inexpensive compared to endoscopy. Background The incidence of oesophageal adenocarcinoma has increased six-fold since the 1970s and survival remains poor despite advances in surgery and chemotherapy. The overall 5-year survival is just 13%. Oesophageal adenocarcinoma is caused by gastro-oesophageal reflux disease (GORD). Reflux is very common; about 20% of adults in the UK suffer from heartburn symptoms caused by GORD. Of these it is estimated that 3-6% will have developed Barrett\u2019s Oesophagus. Barrett\u2019s is caused by reflux and is the precursor of most oesophageal cancers in the UK. However, only about 20% of patients with Barrett\u2019s oesophagus are diagnosed and therefore most people who develop oesophageal adenocarcinoma were unaware they had Barrett\u2019s. This article and image is from Reflux UK, click here to read more.","og_url":"https:\/\/opa-old.voidappsdev.uk\/?p=18394","og_site_name":"The OPA","article_published_time":"2021-04-15T14:31:45+00:00","og_image":[{"width":696,"height":422,"url":"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg","type":"image\/jpeg"}],"author":"OPA","twitter_card":"summary_large_image","twitter_misc":{"Written by":"OPA","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#article","isPartOf":{"@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394"},"author":{"name":"OPA","@id":"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/person\/60271f69edd5545b63ee48b7c7dfcb9f"},"headline":"Cytosponge\u2122","datePublished":"2021-04-15T14:31:45+00:00","dateModified":"2021-04-15T14:31:45+00:00","mainEntityOfPage":{"@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394"},"wordCount":169,"publisher":{"@id":"https:\/\/opa-old.voidappsdev.uk\/#organization"},"image":{"@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage"},"thumbnailUrl":"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg","inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394","url":"https:\/\/opa-old.voidappsdev.uk\/?p=18394","name":"Cytosponge\u2122 - The OPA","isPartOf":{"@id":"https:\/\/opa-old.voidappsdev.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage"},"image":{"@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage"},"thumbnailUrl":"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg","datePublished":"2021-04-15T14:31:45+00:00","dateModified":"2021-04-15T14:31:45+00:00","breadcrumb":{"@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/opa-old.voidappsdev.uk\/?p=18394"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#primaryimage","url":"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg","contentUrl":"https:\/\/opa-old.voidappsdev.uk\/wp-content\/uploads\/2021\/04\/cytosponge-refluxuk.jpg","width":696,"height":422},{"@type":"BreadcrumbList","@id":"https:\/\/opa-old.voidappsdev.uk\/?p=18394#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/opa-old.voidappsdev.uk\/"},{"@type":"ListItem","position":2,"name":"Cytosponge\u2122"}]},{"@type":"WebSite","@id":"https:\/\/opa-old.voidappsdev.uk\/#website","url":"https:\/\/opa-old.voidappsdev.uk\/","name":"The OPA","description":"Caring for the cancer patient &amp; their family","publisher":{"@id":"https:\/\/opa-old.voidappsdev.uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/opa-old.voidappsdev.uk\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/opa-old.voidappsdev.uk\/#organization","name":"The Oesophageal Patients Association","url":"https:\/\/opa-old.voidappsdev.uk\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/logo\/image\/","url":"https:\/\/opa.org.uk\/wp-content\/uploads\/2020\/12\/opa-logo-2020-site-icon.png","contentUrl":"https:\/\/opa.org.uk\/wp-content\/uploads\/2020\/12\/opa-logo-2020-site-icon.png","width":512,"height":512,"caption":"The Oesophageal Patients Association"},"image":{"@id":"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/person\/60271f69edd5545b63ee48b7c7dfcb9f","name":"OPA","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/opa-old.voidappsdev.uk\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/73286462370642845c7dd15b380360bce9236d959ae2fc542c68da2e9ceb468f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/73286462370642845c7dd15b380360bce9236d959ae2fc542c68da2e9ceb468f?s=96&d=mm&r=g","caption":"OPA"}}]}},"_links":{"self":[{"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/posts\/18394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18394"}],"version-history":[{"count":1,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/posts\/18394\/revisions"}],"predecessor-version":[{"id":18396,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/posts\/18394\/revisions\/18396"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=\/wp\/v2\/media\/18395"}],"wp:attachment":[{"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=18394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/opa-old.voidappsdev.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=18394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}